Patient Management, Surgical Applications

Prolonged support with pMCS makeing bridge to scenarios more flexible

Presented by Dr. Alexander Bernhardt

EACTS 2021

Dr. Bernhardt from Hamburg (Germany) demonstrated the usefulness of Impella® 5.0 and 5.5 pumps for bridge to decision making (BTD) in patients with unclear neurological prognosis, where Impella provides not only an excellent survival rate concerning neurological outcomes, but also very few complications. Moreover, he also emphasized the role of Impella in the evaluation of RV function when used as transition from ECLS to Impella 5.0 and 5.5. In the discussion it was added that the Impella does not influence the aortic valve function, and Impella related aortic insufficiency was not observed in his cohort.


View All Posts

Sign up for latest updates

NPS - 624